CUTERA INC. Stock – Fundamental Analysis
Not enough price data available yet.
Fundamental Data & Ratios (Balance sheet update: 3/27/2024)
| Balance Sheet | Total Assets | 355,169,000.00 | ROE | – |
| Balance Sheet | Total Equity | -159,827,000.00 | ROA | – |
| Cashflow | Capital Expenditures | -33,241,000.00 | P/FCF | – |
| Cashflow | Free Cash Flow | -170,880,000.00 | – | – |
| Cashflow | Operating Cash Flow | -137,639,000.00 | P/CF | – |
| Income | Earnings per Share (diluted) | -7.59 | Div. Yield | – |
| Income | Net Income | -150,830,000.00 | P/E | – |
| Income | Shares Outstanding | 19,885,000.00 | P/B | – |
| Income | Total Revenue | 212,369,000.00 | P/S | – |
Ratios calculated on: –
Company Description
Cutera, Inc. is a global medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and light-based aesthetics systems for practitioners worldwide. The Company offers products based on six platforms, which include CoolGlide, Xeo, Solera, GenesisPlus, Excel V, and myQ. Each of the Company´s laser and light-based platforms consists of one or more hand pieces and a console that incorporates a graphic user interface, a laser or light-based module, control system software and high voltage electronics. In addition to systems and upgrades, the Company generates revenue from the sale of post warranty services, Titan hand piece refills, and Dermal filler and cosmeceuticals. Its CoolGlide, Xeo, Solera, GenesisPlus, Excel V and myQ platforms provide the benefits of laser and light-based aesthetic treatments. On February 2, 2012, it completed its acquisition of certain assets of IRIDEX Corporation´s (IRIDEX) global aesthetic business.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.cutera.com
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more